Compass Pathways Plc (CMPS)
11.18
-0.45
(-3.87%)
USD |
NASDAQ |
Oct 23, 16:00
11.30
+0.12
(+1.07%)
Pre-Market: 20:00
Compass Pathways Enterprise Value : 1.138B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.138B |
| October 22, 2026 | 1.199B |
| October 21, 2026 | 1.228B |
| October 20, 2026 | 1.236B |
| October 19, 2026 | 1.129B |
| October 16, 2026 | 1.080B |
| October 15, 2026 | 1.198B |
| October 14, 2026 | 1.150B |
| October 13, 2026 | 1.133B |
| October 12, 2026 | 1.186B |
| October 09, 2026 | 1.250B |
| October 08, 2026 | 1.178B |
| October 07, 2026 | 1.208B |
| October 06, 2026 | 1.190B |
| October 05, 2026 | 1.195B |
| October 02, 2026 | 1.236B |
| October 01, 2026 | 1.243B |
| September 30, 2026 | 1.309B |
| September 29, 2026 | 1.380B |
| September 28, 2026 | 1.417B |
| September 25, 2026 | 1.393B |
| September 24, 2026 | 1.398B |
| September 23, 2026 | 1.487B |
| September 22, 2026 | 1.627B |
| September 21, 2026 | 1.658B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.683B |
| September 17, 2026 | 1.657B |
| September 16, 2026 | 1.494B |
| September 15, 2026 | 1.495B |
| September 14, 2026 | 1.594B |
| September 11, 2026 | 1.569B |
| September 10, 2026 | 1.551B |
| September 09, 2026 | 1.680B |
| September 08, 2026 | 1.526B |
| September 04, 2026 | 1.422B |
| September 03, 2026 | 1.425B |
| September 02, 2026 | 1.417B |
| September 01, 2026 | 1.418B |
| August 31, 2026 | 1.455B |
| August 28, 2026 | 1.484B |
| August 27, 2026 | 1.608B |
| August 26, 2026 | 1.604B |
| August 25, 2026 | 1.640B |
| August 24, 2026 | 1.548B |
| August 21, 2026 | 1.430B |
| August 20, 2026 | 1.497B |
| August 19, 2026 | 1.522B |
| August 18, 2026 | 1.507B |
| August 17, 2026 | 1.483B |
| August 14, 2026 | 1.446B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Silence Therapeutics Plc | 830.94M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -20.75M |
| Mereo BioPharma Group Plc | 15.88M |
| HemoGenyx Pharmaceuticals Plc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -254.25M |
| Total Expenses (Quarterly) | 254.25M |
| EPS Diluted (Quarterly) | -1.883 |
| Earnings Yield | -41.36% |
| Normalized Earnings Yield | -28.93 |